Neoadjuvant nivolumab shows long-term benefit in patients with non–small cell lung cancer
byAmerican Association for Cancer ResearchA–D, Kaplan–Meier curves depicting the recurrence-free survival (A) and overall survival (B) for patients who underwent definitive resection after recei
Updated on: January 13,2024
13
Neoadjuvant nivolumab shows long-term benefit in patients with non–small cell lung cancer
byAmerican Association for Cancer ResearchA–D, Kaplan–Meier curves depicting the recurrence-free survival (A) and overall survival (B) for patients who underwent definitive resection after recei
Updated on:January 13,2024
13
